Press & Media
Newsroom
Resources for journalists and analysts covering Qwyn AI. For interviews, briefings, or additional information, reach our team directly.
Media inquiries
We respond to press requests as quickly as possible.
[email protected]Company facts
- Company
- OperateIQ Inc dba Qwyn AI
- Category
- AI-powered deviation investigation & CAPA management
- Industry
- Life Sciences / Pharmaceutical Quality (GMP)
- Media contact
- [email protected]
Brand assets
Please use the official Qwyn AI logo and name in accordance with our brand guidelines. For high-resolution assets or specific formats, contact our media team.
Download brand assets (.zip)Includes logos, mark, app icon, and partner marks. For other formats, email [email protected].
Latest coverage
Qwyn AI in the news—investor features, founder spotlights, and industry coverage.
gener8tor Founder Series Spotlight: Adam Martin, Qwyn AI
Adam Martin, Co-Founder and CEO of Qwyn AI, on building an AI investigator purpose-built for pharmaceutical manufacturing teams—and reducing drug shortages through faster deviation resolution.
InvestmentWhy We Invested in Qwyn AI
M25's investment thesis on Qwyn AI's AI-powered quality management platform for pharmaceutical manufacturing—and the founder team tackling deviation backlogs.